144 related articles for article (PubMed ID: 28650082)
1. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.
Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K
J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082
[TBL] [Abstract][Full Text] [Related]
2. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
3. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
4. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
5. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
7. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
10. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma.
Sakata J; Hirosue A; Yoshida R; Kawahara K; Matsuoka Y; Yamamoto T; Nakamoto M; Hirayama M; Takahashi N; Nakamura T; Arita H; Nakashima H; Nagata M; Hiraki A; Shinohara M; Nakayama H
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109142
[TBL] [Abstract][Full Text] [Related]
12. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
13. Frequency of circulating CD14
Song Y; Zhou Q; Zhu H; Jing Y; Zhang X; Yang Y; Hu Q; Huang X; Ni Y
J Oral Pathol Med; 2018 Nov; 47(10):923-929. PubMed ID: 29961993
[TBL] [Abstract][Full Text] [Related]
14. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
15. Serum circulating human mRNA profiling and its utility for oral cancer detection.
Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.
Chang KP; Lin SJ; Liu SC; Yi JS; Chien KY; Chi LM; Kao HK; Liang Y; Lin YT; Chang YS; Yu JS
Sci Rep; 2015 Jul; 5():11689. PubMed ID: 26138061
[TBL] [Abstract][Full Text] [Related]
17. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
18. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
19. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY
Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]